SciCombinator

Discover the most talked about and latest scientific content & concepts.

W Kuyken, R Hayes, B Barrett, R Byng, T Dalgleish, D Kessler, G Lewis, E Watkins, C Brejcha, J Cardy, A Causley, S Cowderoy, A Evans, F Gradinger, S Kaur, P Lanham, N Morant, J Richards, P Shah, H Sutton, R Vicary, A Weaver, J Wilks, M Williams, RS Taylor and S Byford
Abstract
Individuals with a history of recurrent depression have a high risk of repeated depressive relapse or recurrence. Maintenance antidepressants for at least 2 years is the current recommended treatment, but many individuals are interested in alternatives to medication. Mindfulness-based cognitive therapy (MBCT) has been shown to reduce risk of relapse or recurrence compared with usual care, but has not yet been compared with maintenance antidepressant treatment in a definitive trial. We aimed to see whether MBCT with support to taper or discontinue antidepressant treatment (MBCT-TS) was superior to maintenance antidepressants for prevention of depressive relapse or recurrence over 24 months.
Tweets*
603
Facebook likes*
122
Reddit*
2
News coverage*
50
Blogs*
16
SC clicks
0
Concepts
Bupropion, Sertraline, Mindfulness-based cognitive therapy, Selective serotonin reuptake inhibitor, Bipolar disorder, Major depressive disorder
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com